1Opitz OG. Telomeres, telomerase and malignant transformation [J]. Current molecular medicine, 2005, 5 (2): 219- 226.
2Cressey TR. Decreased telomerase activity is not a reliable indicator of chemosentivity in testicular cancer cell lines [J]. Europ J Cancer, 2002, (38): 586-593.
3Shats I, Milyavsky M, Tang X, et al. p53-dependent down-regulation of telomerase is mediated by p21wafl [J]. The Journal of Biological Chemistry, 2004, 279 (49): 50976- 50985.
4Misiti S, Nanni S, Fontemaggi G, et al. In duction of hlERT expression and telomerase activity by estrogens in human ovary epithelium cetls [J]. Molecular Cellular Biology, 2000, 20 (11): 3764-3711.
5Yokoyama Y, Takahashi Y, Morishita S, et al. Intro-ductions of P21 (Wafl/Cipl) gene into a carcinoma cell line of the uterine cervix with inactivated p53 [J]. Cancer Letters, 1997, 116 (2): 233-239.
6Ueda M, Ouhtit A, Bito T, et al. Evidence for uv-associated activation of telomerase in human skin [J]. Canecr Reserch, 1997, 57 (3):370-374.
7Xiao X, Sidorov IA, Gee J, et al, Retinoie acid induced down modulatioct of telomerase activity in human cancer cells [J]. Exp MolPathol, 2005, 79 (2): 108-117.
8Yu J, Guo QL, Lin QD, et al. Repression of telomerase revcfse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells [J]. Cancer Chemother Pharmacol, 2006, 58 (4): 434-443.
9Kyo S, Takakura M, Taira T, et al. spl cooperates with c-myc to activate transcription of the human telomerase transcriptase gene (hTERT) [J]. Nucleic Acids Reserch, 2000, 28 (3): 669-677.
10Falchetti A, Bechedni L, Martineti V, et al. Telomerase repeat amplification protocol (TRAP) : A new molecular marker for parathyroid [J]. carcinoma Biochem Biophys Res Commun, 1999, 265 (1): 252-255.
2Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer, 1997,33: 787-791.
3Chatziantoniou VD. Telomerase: biological function and potential role in cancer management. Pathol Oncol Res, 2001, 7:161-170.
4Hoos A, Hepp HH, Kaul S, et al. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer, 1998, 79: 8-12.
5Tangkijvanich P, Tresukosol D, Sampatanukul P, et al. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites. Clin Cancer Res, 1999, 5:2470-2475.
6Hahn WC, Counter CM, Lundberg AS, et al.Creation of human tumour cells with defined genetic elements. Nature, 1999,400:464-468 .
7Holt SE,Glinsky VV,Ivanova AB,et al.Resistance to apoptosis is in human cell conffered by telomerase function and telomere stability.Mol Carcinog, 1999.25:241-248.
8Lipardi C,Wei Q,Paterson BM.RNAi as random degradative PCR:siRNA primer convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell,2002,107:297-307.
